Brief: RaQualia Pharma gets substance patent for ghrelin receptor agonist(serine derivative) in Japan
06/10/2016 05:14
Oct 6 (Reuters) - RaQualia Pharma Inc 4579.T :
* Says it received substance patent for ghrelin receptor
agonist(serine derivative) in Japan
* Says the substance is used for improvement of anorexia and
suppression of body weight reduction
Source text in Japanese:https://goo.gl/QRT4mA
Further company coverage: 4579.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724;
Reuters Messaging: jun.cao.reuters.com@reuters.net))